Literature DB >> 25834199

Low levels of serum uric Acid increase the risk of low bone mineral density in young male patients with ankylosing spondylitis.

Kwi Young Kang1, Yeon Sik Hong1, Sung-Hwan Park1, Ji Hyeon Ju2.   

Abstract

OBJECTIVE: Uric acid (UA) has antiosteoporotic effects in postmenopausal women. This study investigated the association between serum UA levels and bone mineral density (BMD) in young male patients with ankylosing spondylitis (AS).
METHODS: One hundred fifty patients who fulfilled the modified New York criteria for the classification of AS were analyzed. All patients were male and under 50 years of age. BMD, serum UA concentrations, clinical variables, and radiographic progression were assessed. The associations between UA and BMD at the lumbar spine and hip were evaluated using multiple linear regression analysis. Multivariate logistic regression analyses were performed to identify risk factors associated with low BMD.
RESULTS: Mean serum UA concentration in the 150 patients with AS was 5.5 ± 1.3 mg/dl. BMD at the lumbar spine, but not at the total hip and femoral neck, increased with increasing serum UA tertiles (p = 0.033). The significant positive association between serum UA and BMD at the lumbar spine remained after adjustment for confounding factors (β = 0.185, p = 0.014, adjusted R(2) = 0.310). Multiple logistic regression analyses showed that lower UA concentrations (OR 4.02, 95% CI 1.34-12.3) and body mass index and increased erythrocyte sedimentation rate were independently associated with the risk of low BMD.
CONCLUSION: Lower serum UA levels are associated with lower BMD in young male patients with AS. UA may be a novel predictive marker or therapeutic target in patients with AS.

Entities:  

Keywords:  ANKYLOSING SPONDYLITIS; ANTIOXIDANT; BONE MINERAL DENSITY; OSTEOPOROSIS; URIC ACID

Mesh:

Substances:

Year:  2015        PMID: 25834199     DOI: 10.3899/jrheum.140850

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.

Authors:  M Pirro; M R Mannarino; V Bianconi; S De Vuono; A Sahebkar; F Bagaglia; L Franceschini; A M Scarponi; E Mannarino; T Merriman
Journal:  Osteoporos Int       Date:  2016-10-10       Impact factor: 4.507

2.  Should clinicians pay more attention to the potential underdiagnosis of osteoporosis in patients with ankylosing spondylitis? A national population-based study in Taiwan.

Authors:  Li-Yu Hu; Ti Lu; Pan-Ming Chen; Cheng-Che Shen; Yao-Min Hung; Chiao-Lin Hsu
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

3.  Serum Uric Acid Shows Inverted "U" Type Correlation with Osteoporosis in Chinese Ankylosing Spondylitis Patients: A Retrospective Study.

Authors:  Zhixin Chen; Peidan Yang; Yuyun Wu; Xiaobao Liu; Yechun Yang; Pingfang Song; Yimin Talia Chen; Changsong Lin; Qiang Xu
Journal:  Med Sci Monit       Date:  2019-12-18

4.  The serum uric acid is longitudinally related to patients global assessment of disease activity in male patients with axial spondyloarthritis.

Authors:  Meimei Cai; Wen Liu; Yuanhui Wu; Qing Zheng; Dehao Liu; Guixiu Shi
Journal:  BMC Musculoskelet Disord       Date:  2022-07-27       Impact factor: 2.562

5.  Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis.

Authors:  Han-Na Lee; Aran Kim; Yunkyung Kim; Geun-Tae Kim; Dong Hyun Sohn; Seung-Geun Lee
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.